Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4-positive T cell receptors (TCRs) are antigen-specific receptors expressed on the surface of CD4+ T cells, a subset of lymphocytes critical for adaptive immunity. They recognize peptide antigens presented by MHC-II molecules on antigen-presenting cells. The TCR complex, along with the CD4 co-receptor, initiates signaling cascades that lead to T cell activation, proliferation, and differentiation, orchestrating immune responses against pathogens and contributing to immune regulation. Dysregulation of CD4+ TCR function is implicated in various diseases, including infections (e.g., HIV), autoimmunity, and cancer.
Modulation of T cell activation, blocking T cell-APC interaction
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4-positive T cell receptor (CD4+ TCR).